MURA Insider Trading Activity and SEC Form 4 Filings
MURA insider trading summary
Over the past 12 months, insiders at Mural Oncology plc (MURA) reported 1 sale worth $10K by 1 insider and no open-market purchases on SEC Form 4. Net insider selling was $10K.
Latest MURA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 10, 2025 | Vicki L Goodman | Chief Medical Officer | Sell | $10K (5,036 @ $2.08) |
| Nov 3, 2025 | Adam D. Cutler | Chief Financial Officer | Sell | $15K (7,148 @ $2.09) |
| Jul 22, 2025 | Maiken Keson-Brookes | See Remarks | Sell | $6K (2,572 @ $2.48) |
| Jul 18, 2025 | Maiken Keson-Brookes | See Remarks | Sell | $5K (2,158 @ $2.48) |
| Jul 7, 2025 | Caroline Loew | Chief Executive Officer | Sell | $30K (12,531 @ $2.43) |
| Mar 5, 2025 | Maiken Keson-Brookes | See Remarks | Sell | $5K (1,469 @ $3.45) |
| Mar 4, 2025 | Caroline Loew | Chief Executive Officer | Sell | $14K (4,313 @ $3.36) |
| Mar 4, 2025 | Maiken Keson-Brookes | See Remarks | Sell | $4K (1,262 @ $3.36) |
| Feb 24, 2025 | Vicki L Goodman | Chief Medical Officer | Sell | $51K (13,186 @ $3.89) |
| Dec 23, 2024 | Maiken Keson-Brookes | See Remarks | Sell | $8K (2,555 @ $3.27) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.